CERCARE Perfusion and CERCARE Stroke enable fast brain tissue viability analysis
Edinburgh, UK – December 3, 2020 – Blackford, the provider of the dedicated platform for medical imaging applications and AI, today announced its partnership with Cercare Medical to make their AI imaging solutions, CERCARE Perfusion and CERCARE Stroke, available on Blackford Platform.
Developed by Cercare Medical, the AI-powered imaging solutions provide unparalleled decision support to radiology professionals. CERCARE Perfusion is a fully automated solution that allows to save time while providing high quality perfusion maps for brain CT and MRI. CERCARE Stroke helps stroke teams beat the clock with AI-powered decision support for stroke CT and MRI.
Fully integrated with existing systems, Blackford Platform simplifies implementing and managing of multiple imaging applications and AI algorithms and reduces load on PACS. New applications can easily be added to the image-processing platform, reducing implementation time, costs, and long-term maintenance.
“Blackford has shown to be a reliable partner for both clinicians and software providers,” said Mikkel Bo Hansen, founder and CSO, Cercare Medical. “The Blackford platform makes innovative technology easily available to healthcare professionals, so we are happy to be working together as one of Blackford’s partners.”
About Cercare Medical
Cercare Medical is a medical software company founded in 2013 as a spin-out of the Center of Functionally Integrative Neuroscience and MINDlab research centers at Aarhus University. Cercare Medical extends more than 20 years of research in neuroimaging and artificial intelligence led by Professor Leif Østergaard and Professor Kim Beuschau Mouridsen. Current CE-approved portfolio consists of AI-powered solutions for fast brain tissue viability analysis in a range of neurological disorders including oncology, dementia, and stroke. For more information, please visit www.cercare-medical.com
Blackford provides a single platform to quickly access and manage a curated marketplace of regulatory approved medical image analysis applications and AI algorithms that add clinical value. Easily integrated into existing workflows, the platform provides actionable information that allows healthcare providers to use imaging information smartly and reduce the cost of care, while improving diagnostic confidence and patient outcomes. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by TRI Cap, Old College Capital, and Archangel Investors, one of the UK’s leading business angel syndicates. www.blackfordanalysis.com